Inventor · disambiguated record
David Coughlan
Also filed as: COUGHLAN DAVID · COUGHLAN DAVID C
25 granted patents·30 pending applications·79 citations·filing 2009–2025
94Inventor score
Top patents by PatentIndex Score
55 records- 0195US10231945B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2017·Granted Mar 19, 2019·8 cites·10 claims
- 0295US9855238B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2016·Granted Jan 2, 2018·8 cites·6 claims
- 0394US8293790B2Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereofMANKU MEHAR·Filed 2012·Granted Oct 23, 2012·23 cites·11 claims
- 0493US10105333B2Pharmaceutical compositions comprising DGLA and use of sameDS BIOPHARMA LTD·Filed 2017·Granted Oct 23, 2018·9 cites·10 claims
- 0592US10849870B2Pharmaceutical compositions comprising DGLA and use of sameDS BIOPHARMA LTD·Filed 2019·Granted Dec 1, 2020·1 cites·18 claims
- 0692US9682055B2Pharmaceutical compositions comprising DGLA and use of sameDIGNITY SCIENCES LTD·Filed 2015·Granted Jun 20, 2017·8 cites·6 claims
- 0790US9056086B2Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereofDIGNITY SCIENCES LTD·Filed 2012·Granted Jun 16, 2015·13 cites·44 claims
- 0881US12274685B2Compositions comprising 15-HEPE and methods of using the sameAFIMMUNE LTD·Filed 2022·Granted Apr 15, 2025·0 cites·18 claims
- 0981US8936803B2Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereofDIGNITY SCIENCES LTD·Filed 2012·Granted Jan 20, 2015·5 cites·10 claims
- 1080US10537543B2Pharmaceutical compositions comprising DGLA and use of sameDS BIOPHARMA LTD·Filed 2019·Granted Jan 21, 2020·1 cites·14 claims
- 1178US12017986B2Compositions comprising oxo-derivatives of fatty acids and methods of making and using sameDS BIOPHARMA LTD·Filed 2021·Granted Jun 25, 2024·0 cites·5 claims
- 1278US2025281442A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1376US10716773B2Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic diseaseAFIMMUNE LTD·Filed 2018·Granted Jul 21, 2020·1 cites·8 claims
- 1475US11478442B2Pharmaceutical compositions comprising DGLA and use of sameDS BIOPHARMA LTD·Filed 2020·Granted Oct 25, 2022·0 cites·12 claims
- 1572US2025017887A1Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseasesAFIMMUNE LTD·Filed 2024·Application pending·0 cites
- 1672US2019224154A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1771US2021230094A1Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using SameDS BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 1870US12076304B2Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseasesAFIMMUNE LTD·Filed 2022·Granted Sep 3, 2024·0 cites·9 claims
- 1970US2020181064A1Pharmaceutically acceptable salts of fatty acidsDS BIOPHARMA LTD·Filed 2019·Application pending·0 cites
- 2067US9855236B2Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereofDIGNITY SCIENCES LTD·Filed 2014·Granted Jan 2, 2018·0 cites·7 claims
- 2166US10570083B2Compositions comprising oxo-derivatives of fatty acids and methods of making and using sameDS BIOPHARMA LTD·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 2265US8999383B2Compositions of GnRH related compounds and processes of preparationLEE AMANDA·Filed 2009·Granted Apr 7, 2015·2 cites·32 claims
- 2365US2018214408A1Pharmaceutical compositions comprising dgla and use of sameDS BIOPHARMA LTD·Filed 2018·Application pending·0 cites
- 2464US2018104208A1Pharmaceutical compositions comprising dgla and use of sameDS BIOPHARMA LTD·Filed 2017·Application pending·0 cites
- 2563US2021085628A1Compositions comprising 15-hepe and methods of treating or preventing cancer and neurologic diseaseAFIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2662US2017071890A1Pharmaceutical compositions comprising dgla and use of sameDIGNITY SCIENCES LTD·Filed 2016·Application pending·0 cites
- 2762US2013274338A1Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using sameDIGNITY SCIENCES LTD·Filed 2013·Application pending·0 cites
- 2861US10017453B2Pharmaceutically acceptable salts of fatty acidsDIGNITY SCIENCES LTD·Filed 2014·Granted Jul 10, 2018·0 cites·5 claims
- 2961US2013267598A1Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using sameDIGNITY SCIENCES LTD·Filed 2013·Application pending·0 cites
- 3060US10047033B2Compositions comprising oxo-derivatives of fatty acids and methods of making and using sameDIGNITY SCIENCES LTD·Filed 2016·Granted Aug 14, 2018·0 cites·19 claims
- 3159US9670126B2Methods of making 15-hydroxy fatty acid derivativesDIGNITY SCIENCES LTD·Filed 2014·Granted Jun 6, 2017·0 cites·15 claims
- 3258US10544088B2Pharmaceutically acceptable salts of fatty acidsDS BIOPHARMA LTD·Filed 2017·Granted Jan 28, 2020·0 cites·3 claims
- 3358US9192674B2Cosmetic compositions comprising EPA and GLA and methods of making and using sameDIGNITY SCIENCES LTD·Filed 2013·Granted Nov 24, 2015·0 cites·19 claims
- 3458US8673325B1Cosmetic compositions comprising EPA and salicylic acid and methods of making and using sameDIGNITY SCIENCES LTD·Filed 2013·Granted Mar 18, 2014·0 cites·20 claims
- 3556US2015094370A1Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using sameDIGNITY SCIENCES LTD·Filed 2014·Application pending·0 cites
- 3653US2021315851A1Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseasesAFIMMUNE LTD·Filed 2020·Application pending·0 cites
- 3752US2019216761A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 3852US2014171358A1Antimicrobial compositions comprising dgla and neomycin sulfate and methods of use thereofDIGNITY SCIENCES LTD·Filed 2014·Application pending·0 cites
- 3951US2015290225A1Compositions and methods of using sameDIGNITY SCIENCES LTD·Filed 2015·Application pending·0 cites
- 4051US2017020836A1Compositions Comprising 15-HEPE and Methods of Treating or Preventing Cancer and Neurologic DiseaseDIGNITY SCIENCES LTD·Filed 2016·Application pending·0 cites
- 4151US2019175534A1Pharmaceutical compositions comprising dgla and use of sameDS BIOPHARMA LTD·Filed 2018·Application pending·0 cites
- 4248US2012264705A1Antimicrobial compositions comprising 15-hetre and methods of use thereofMANKU MEHAR·Filed 2012·Application pending·0 cites
- 4347US2017232021A1Compositions and methods of using sameAFIMMUNE LTD·Filed 2017·Application pending·0 cites
- 4447US2022133669A1Pharmaceutical compositions comprising 15-hetre and methods of use thereofDS BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 4546US2020360331A1COMPOSITIONS COMPRISING 15-HEPE AND/OR 15-HETrE AND METHODS OF TREATING OR PREVENTING CARDIOMETABOLIC DISEASE, METABOLIC SYNDROME, AND/OR RELATED DISEASESAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 4646US2017196825A1Pharmaceutical compositions comprising dgla and use of sameDIGNITY SCIENCES LTD·Filed 2017·Application pending·0 cites
- 4745US2021085627A1Methods of treating diseases and disorders using compositions comprising 18-hepe, 12-hepe, or combinations thereofAFIMMUNE LTD·Filed 2019·Application pending·0 cites
- 4844US2018008567A1Compositions comprising 15-hepe and methods of using the sameAFIMMUNE LTD·Filed 2016·Application pending·0 cites
- 4944US2018333382A1Pharmaceutical compositions comprising dgla and use of sameDS BIOPHARMA LTD·Filed 2018·Application pending·0 cites
- 5043US2021322354A1Methods of treating inflammatory, fibrotic, and proliferative conditions using compositions comprising dgla and/or 15-hetre, and associated methods and compositionsDS BIOPHARMA LTD·Filed 2020·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Coughlan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →